Literature DB >> 2120380

Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro.

H D Mason1, H Martikainen, R W Beard, V Anyaoku, S Franks.   

Abstract

In-vitro studies in both rodents and man suggest that GH can stimulate ovarian steroidogenesis, but it is not clear whether this effect is mediated by changes in circulating concentrations of insulin-like growth factor-1 (IGF-1) or whether it is a direct action on the ovary (or, indeed, both). In this study the effects of biosynthetic human GH (hGH) on the production of oestradiol and IGF-1 by human granulosa cells in culture were examined using ovarian tissue (from both normal and polycystic ovaries) which had not previously been exposed to exogenous gonadotrophin therapy. Addition of hGH (1 or 10 ng/ml) to the incubation medium resulted in a significant (1.7 to 3.6 fold) increase in oestradiol accumulation after 48h in culture. Human GH also had a significant additive effect on the dose-related responsiveness of granulosa cell oestradiol production to hFSH. Concentrations of IGF-1 in the medium were undetectable in each of these experiments. These studies demonstrate that hGH has a potent, direct stimulatory effect on production of oestradiol by the human ovary which is independent of the effect of FSH. These findings have important implications for understanding the physiological role of hGH in human ovarian function as well as for therapeutic use of biosynthetic hGH for induction of ovulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120380     DOI: 10.1677/joe.0.126r001

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  14 in total

1.  Growth hormone and in vitro maturation of rhesus macaque oocytes and subsequent embryo development.

Authors:  Jenna K Nyholt de Prada; Catherine A VandeVoort
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

2.  Growth hormone (GH) and reproduction: a review.

Authors:  F Le Gac; O Blaise; A Fostier; P Y Le Bail; M Loir; B Mourot; C Weil
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

3.  Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center.

Authors:  Sema Ciftci Dogansen; Seher Tanrikulu; Gulsah Yenidunya Yalin; Sema Yarman
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

Review 4.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 5.  Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization.

Authors:  P G Artini; A A de Micheroux; F Taponeco; V Cela; G D'Ambrogio; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

Review 6.  Growth hormone for in vitro fertilisation (IVF).

Authors:  Akanksha Sood; Gadha Mohiyiddeen; Gaity Ahmad; Cheryl Fitzgerald; Andrew Watson; Lamiya Mohiyiddeen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 7.  Growth hormone for in vitro fertilization.

Authors:  James Mn Duffy; Gaity Ahmad; Lamiya Mohiyiddeen; Luciano G Nardo; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down syndrome.

Authors:  R M Cento; L Ragusa; C Proto; A Alberti; G Fiore; L Soranna; F Colabucci; A Lanzone
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

9.  Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial.

Authors:  Tansu Kucuk; Hakan Kozinoglu; Ayten Kaba
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

10.  Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status.

Authors:  Sun Young Shin; Jung Ryeol Lee; Gyung Woon Noh; Hyun Joo Kim; Won Jun Kang; Seok Hyun Kim; June-Key Chung
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.